TY - JOUR
T1 - Pharmacokinetics of calcium absorption from two commercial calcium supplements
AU - Heller, H. J.
AU - Stewart, A.
AU - Haynes, S.
AU - Pak, C. Y C
PY - 1999
Y1 - 1999
N2 - This study was conducted to compare pharmacokinetic indices of calcium absorption after a single oral (500 mg calcium) load of Citracal (calcium citrate) and Os-Cal (calcium carbonate). In 18 postmenopausal normal women, venous blood samples were obtained for the measurement of calcium before and hourly for 6 hours after an oral ingestion of Citracal, Os-Cal, or placebo with a breakfast meal. The change in area under the curve (ΔAUC) in serum calcium from preload was 2.5-fold greater for Citracal than Os-Cal, and the peak-basal variation in serum calcium was 76% higher for Citracal than Os-Cal. The increment in serum calcium from preload after Citracal administration was significantly higher than that obtained after placebo load during most time periods and significantly higher than that of Os-Cal at 1, 4, and 5 hours after load. In contrast, (ΔAUC) and peak basal variation of Os-Cal did not differ significantly from placebo, and increment in serum calcium was significantly increased from placebo only at 6 hours. In conclusion, Citracal is much more bioavailable than Os-Cal. (C) 1999 the American College of Clinical Pharmacology.
AB - This study was conducted to compare pharmacokinetic indices of calcium absorption after a single oral (500 mg calcium) load of Citracal (calcium citrate) and Os-Cal (calcium carbonate). In 18 postmenopausal normal women, venous blood samples were obtained for the measurement of calcium before and hourly for 6 hours after an oral ingestion of Citracal, Os-Cal, or placebo with a breakfast meal. The change in area under the curve (ΔAUC) in serum calcium from preload was 2.5-fold greater for Citracal than Os-Cal, and the peak-basal variation in serum calcium was 76% higher for Citracal than Os-Cal. The increment in serum calcium from preload after Citracal administration was significantly higher than that obtained after placebo load during most time periods and significantly higher than that of Os-Cal at 1, 4, and 5 hours after load. In contrast, (ΔAUC) and peak basal variation of Os-Cal did not differ significantly from placebo, and increment in serum calcium was significantly increased from placebo only at 6 hours. In conclusion, Citracal is much more bioavailable than Os-Cal. (C) 1999 the American College of Clinical Pharmacology.
UR - http://www.scopus.com/inward/record.url?scp=0033338731&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033338731&partnerID=8YFLogxK
M3 - Article
C2 - 10579145
AN - SCOPUS:0033338731
SN - 0091-2700
VL - 39
SP - 1151
EP - 1154
JO - Journal of Clinical Pharmacology
JF - Journal of Clinical Pharmacology
IS - 11
ER -